Matching slides 37,461
Current window 17,371-17,400
Pages 1,249
Rows per page 30

Beat

17,371-17,400 of 37,461

filter-aware
15
The slide uses a series of line charts to demonstrate efficacy across different antibody affinities.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The slide compares initial monotherapy survival against a re-challenge survival study.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The diagram shows a multi-step process involving opsonization, NK cells, macrophages, dendritic cells (DC), and T-cell activation via CD137.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a series of small-multiple line charts to show tumor growth over time and a Kaplan-Meier survival curve to show efficacy.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
The slide includes a Kaplan-Meier plot showing PFS outcomes for different patient cohorts (PD-1 refractory, immune competent).Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
Includes a pharmacokinetic simulation graph and a conceptual dose-response curve illustrating that maximal receptor occupancy may not correlate with optimal biological response.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
21
The slide presents two distinct tables: one for patient demographics/clinical history and one for cancer indications.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
22
The slide uses red arrows for primary categories and blue arrows for sub-points.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
23
Includes CT scan imagery as evidence of efficacy.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
24
Clinical trial update slide.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses flags to represent markets, with a central callout box defining 'leading position'.Deliveroo | Market Presentation Deck | 8 slides · OC&C
Consulting deck Investor relations Beat · Competition1 hit
07
The chart uses a line graph to show performance across criteria, with annotations explaining specific data points.Deliveroo | Market Presentation Deck | 8 slides · OC&C
Consulting deck Investor relations Beat · SolutionLoop · Benchmark Gap1 hit
08
The slide uses a matrix-like structure to map parent companies to their subsidiaries.Embracer Group | Mergers and Acquisitions Presentation Deck | 11 slides · Embracer Group
Conference presentation Investment bank Beat · What Could BeLoop · Quick Win Big Bet1 hit
09
Mentions a specific leverage target of 1.0x operational EBIT to net debt.Embracer Group | Mergers and Acquisitions Presentation Deck | 11 slides · Embracer Group
Conference presentation Investment bank Beat · What Could BeLoop · Quick Win Big Bet1 hit
06
Includes confidential watermarks on project pipeline metrics.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
07
Includes headshots of three leaders and an org chart showing the relationship between the operating unit and its subsidiaries.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
08
The background is a pinball game theme.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
09
Includes Embracer Group branding in top right corner.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
10
The slide combines company branding, speaker introductions, and social proof via press quotes.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
11
Includes deal terms for the acquisition of Snapshot Games by Embracer Group.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
12
The slide features a high-fantasy battle scene as background art.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
13
Slide 13 of an Embracer Group presentation.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
14
Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slidesEmbracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
15
Slide provides a company profile for an acquisition target.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · SolutionLoop · Pattern Hunter1 hit
31
Includes WHO data visualization of regional HBV prevalence.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
32
The slide presents three line charts showing dose-response curves for EVT895 (labeled Abk77) versus Pegasys.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
33
The slide highlights the strategic alliance between Bayer and Evotec, combining expertise in inflammation/women's health with pain research.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
34
The slide uses a simple illustration of a coughing person to emphasize the condition.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
35
Includes a chart showing mean relative change in cough frequency vs placebo across four dose levels.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
36
The slide uses a side-by-side comparison structure to frame the clinical need for two distinct patient populations.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit